Drug repurposing to combat a global bacterial zoonosis

Our project aims to evaluate a new drug to treat brucellosis, an infectious disease transmissible to humans by certain domestic animals (cows or goats). This debilitating disease affects around 1 million new people each year. The advantage of this candidate drug is that it is already being used to treat another disease, which would significantly reduce the costs and validation time to be able to use it to control brucellosis.